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ABSTRACT 
The aim of this present work was to develop stability indicating LC method, which is selective, accurate, simple, precise, reliable, 
cost effective and rapid for the quantification of all possible degradants and determination of exemestane. In addition, to develop and 
validate Stability Indicating Method for the determination of impurities (degradation products) in exemestane API by RP-HPLC. 
Finally, validate the developed method as per ICH guidelines. 
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INTRODUCTION:  
The principle of chromatographic methods consists in the 
unequal distribution of components of a mixture between 
the stationary and the mobile phase. The prerequisite for 
an unequal distribution is the different possibility of 
diffusion into them
1-3
. 
 Classification of Chromatography: 
 
Figure 2: Various components of HPLC are as 
follows 
 Figure 1: Types of chromatography 
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Method Development in HPLC 
Method development and optimization in liquid 
chromatography is still an attractive field of research for 
theoreticians (researchers) and attracts also a lot of 
interest from practical analysts. “Optimized column, 
mobile phase, best detection wavelength, efforts in 
separation can make a world of difference, while 
developing HPLC method for routine analysis. 
Determining the ideal combination of these factors 
assures faster delivery of desired results and a validated 
method of separation
3-5
. 
MATERIALS AND METHODS:  
Exemestane was received from Cadila Healthcare, 
Ahmedabad, HPLC grade acetonitrile was purchased 
from Merck Specialities Private Limited, Mumbai, India. 
Double distilled water along with acetonitrile was used 
as diluent throughout the study. 
-Selection of Analytical Technique 
 HPLC method 
- Selection of method for evaluation (either Reverse 
Phase Chromatography or Normal Phase 
Chromatography)  
 -Method development and validate for determination 
of impurities (degradation products) and of 
exemestane by using RP-HPLC. 
-Selection of different stress studies:  
As per ICH guidelines Q1A (R2), different stress 
conditions were selected and applied to drug for forced 
degradation studies. 
-Validation of method which involves. Specificity  
Accuracy. Linearity. Precision.Robustness. Limit of 
Detection (LOD), Limit of Quantitation (LOQ), 
Compilation of data.  
RESULT AND DISCUSSION:  
Selection of Mobile phase 
Different mobile phase systems like methanol: water, 
acetonitrile: water were tried in order to determine the 
best composition for separation of exemestane. It was 
found that acetonitrile: water (60:40 % v/v) by isocratic 
elution gives good resolution and satisfactory peak 
symmetry as compared to others. Finally this mobile 
phase was found to be most suitable. The chromatogram 
obtained by using acetonitrile: water (60:40 %v/v) as 
mobile phase is shown below in Fig. 3. 
Figure 3:   Chromatogram of a 10 µgmL
-1
 solution of 
exemestane 
 Calibration Curve 
Table shows the peak area observed for various 
concentrations of standard exemestane solutions. The 
graph of Peak Area (µV*sec) vs. Concentration (ppm) 
was plotted in figure. 
Table 1: Standard calibration curve for exemestane 
S. N. Concentration (ppm) Peak Area (µV*sec) 
1. 4 584173.86 
2. 6 792628.08 
3. 8 966578.04 
4. 10 1171116.28 
5. 12 1353103.47 
6. 14 584173.86 
 
Method development 
Detection wavelength for the HPLC study was selected 
as 242 nm. The chromatographic conditions were 
optimized for resolution of the peak of the drug and 
degradation products under each forced degradation 
condition by varying the proportion of acetonitrile/water 
in the mobile phase. Subsequently, a mixture of samples 
of different stress conditions was used to optimize the 
chromatographic conditions for resolving exemestane 
and all the degradation products in a single run. An 
appropriate blank was injected before the analysis of all 
forced degradation samples. Such an optimized method 
was then used to study the forced degradation behavior 
of exemestane and was also applied in the determination 
of exemestane. 
Method Validation 
Linearity: Peak areas obtained with respective 
concentrations were subjected to the least square linear 
regression analysis to calculate the calibration equations 
and correlation coefficients.  The calibration plot for 
exemestane assay was linear over the calibration range 
6–14 μgmL–1 and the regression coefficient, slope and 
intercept were found to be 0.9997,96854 and 4147.6 
respectively (In Table). The calibration curve of 
exemestane is shown below in Fig. 
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Figure 4: Calibration curve of exemestane 
Table 2: Linearity range, slope, intercept and correlation coefficient for Calibration curve 
Drug Linearity range 
(µgmL
-1
) 
Slope Intercept Correlation 
coefficient 
Exemestane 4-14 96854 4147.6 0.9997 
 
CONCLUSION: 
The analytical method described in this paper is suitable 
for determination of exemestane and this method has 
been demonstrated to be accurate, linear, precise, 
repeatable, specific, and robust, and therefore suitable 
for routine analysis of exemestane. 
This method is a stability indicating method because it 
can separate all known degradation products from 
exemestane (API).  
The stability indicating method that has been reported in 
the literature uses 100% organic modifier as the mobile 
phase and by this method drug has an retention time of 
greater than 20 min which is costly and time consuming. 
So, this present method was found to be cost effective 
and rapid. 
From the results of the forced degradation studies it can 
be concluded that drug was found to degrade rapidly by 
oxidation, followed by base hydrolysis, acid hydrolysis, 
dry heat and neutral catalyzed degradation.  
As the method is successfully validated using ICH 
guidelines, it can be readily implemented in quality 
control laboratories for the purpose of lot release and 
stability testing of Exemestane API. 
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